A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases	Neoplasms by Site, Skin and Connective Tissue Diseases, brain disorder, breast disorder, breast neoplasm, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder, skin disorder	Recruiting	Phase 2	2026-08-21		NCT06764940

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Biostar Pharma, Inc.	1

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Augusta University	Augusta	United States	57
City of Hope--Duarte	Duarte	United States	1
Community Clinical Trials	Kingwood	United States	1
Comprehensive Cancer Centers of Nevada	Las Vegas	United States	34
MD Anderson Cancer Center	Houston	United States	589
Robert H. Lurie Comprehensive Cancer Center Northwestern University	Chicago	United States	1
Scripps Health	San Diego	United States	7
Stony Brook Cancer Center	Stony Brook	United States	1
The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine	Baltimore	United States	1
Tranquil Clinical Research	Webster	United States	11
Univ. of California Los Angeles	Los Angeles	United States	1
University of Colorado Hospital - Anschutz Cancer Pavilion	Aurora	United States	13